Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio Key International (BKYI) Asset Writedowns and Impairment (2017 - 2025)

Bio Key International's Asset Writedowns and Impairment history spans 5 years, with the latest figure at -$15000.0 for Q3 2025.

  • For Q3 2025, Asset Writedowns and Impairment rose 84.83% year-over-year to -$15000.0; the TTM value through Sep 2025 reached $82610.0, up 105.91%, while the annual FY2024 figure was -$16265.0, 97.83% up from the prior year.
  • Asset Writedowns and Impairment for Q3 2025 was -$15000.0 at Bio Key International, down from $15000.0 in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $1.5 million in Q2 2023 and bottomed at -$1.3 million in Q4 2023.
  • The 3-year median for Asset Writedowns and Impairment is -$15000.0 (2025), against an average of -$85140.6.
  • The largest YoY upside for Asset Writedowns and Impairment was 106.35% in 2024 against a maximum downside of 106.67% in 2024.
  • A 3-year view of Asset Writedowns and Impairment shows it stood at -$1.3 million in 2023, then surged by 106.35% to $82610.0 in 2024, then plummeted by 118.16% to -$15000.0 in 2025.
  • Per Business Quant, the three most recent readings for BKYI's Asset Writedowns and Impairment are -$15000.0 (Q3 2025), $15000.0 (Q1 2025), and $82610.0 (Q4 2024).